These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 17431406)

  • 1. Development trends for monoclonal antibody cancer therapeutics.
    Reichert JM; Valge-Archer VE
    Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development trends for new cancer therapeutics and vaccines.
    Reichert JM; Wenger JB
    Drug Discov Today; 2008 Jan; 13(1-2):30-7. PubMed ID: 18190861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in medical oncology].
    Shi YK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-conjugated monoclonal antibodies for the treatment of cancer.
    Lambert JM
    Curr Opin Pharmacol; 2005 Oct; 5(5):543-9. PubMed ID: 16087399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of antibodies as cancer drugs.
    Reichert JM; Dhimolea E
    Drug Discov Today; 2012 Sep; 17(17-18):954-63. PubMed ID: 22561895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing antibody and small-molecule therapies for cancer.
    Imai K; Takaoka A
    Nat Rev Cancer; 2006 Sep; 6(9):714-27. PubMed ID: 16929325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Future cancer care challenges the health care].
    Olofsson S
    Lakartidningen; 2010 Apr 21-27; 107(16):1065. PubMed ID: 20476702
    [No Abstract]   [Full Text] [Related]  

  • 10. Principles of the therapeutic use of monoclonal antibodies in oncology.
    Fridman WH
    C R Biol; 2006 Apr; 329(4):255-9. PubMed ID: 16644495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASCO 2011: broadening the horizons of cancer research.
    Crane K
    J Natl Cancer Inst; 2011 Jul; 103(13):999-1001. PubMed ID: 21693729
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curtailing the high rate of late-stage attrition of investigational therapeutics against unprecedented targets in patients with lung and other malignancies.
    Rowinsky EK
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4220s-4226s. PubMed ID: 15217962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of humanized antibodies as cancer therapeutics.
    Qu Z; Griffiths GL; Wegener WA; Chang CH; Govindan SV; Horak ID; Hansen HJ; Goldenberg DM
    Methods; 2005 May; 36(1):84-95. PubMed ID: 15848077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanistic perspective of monoclonal antibodies in cancer therapy beyond target-related effects.
    Strome SE; Sausville EA; Mann D
    Oncologist; 2007 Sep; 12(9):1084-95. PubMed ID: 17914078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted and tailored therapy in hemato-oncology: vision for the 21st century.
    Shpilberg O; Ben-Bassat I; Raanani P
    Isr Med Assoc J; 2006 Dec; 8(12):843-4. PubMed ID: 17214100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in research on monoclonal antibody agents for cancer therapy].
    Zhen Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):9-13. PubMed ID: 12903485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New targets and targeted drugs for the treatment of cancer: an outlook to pediatric oncology.
    Rossig C; Juergens H; Berdel WE
    Pediatr Hematol Oncol; 2011 Oct; 28(7):539-55. PubMed ID: 21936619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of scientific progress: growing inequalities in the delivery of cancer care.
    Mano M
    Acta Oncol; 2006; 45(1):84-6. PubMed ID: 16464800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology evaluation: SGN-15, Seattle Genetics Inc.
    Smith S
    Curr Opin Mol Ther; 2001 Jun; 3(3):295-302. PubMed ID: 11497354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.